Why should the VCID field care about what’s happening with amyloid therapeutics?
Donna Wilcock, PhD
9:20 am
From Dark Horse to Front-Runner: Vascular contributions to brain health
Farzaneh Sorond, MD, PhD
10:00 am
Blood-brain barrier dysfunction is associated with A/T/N biomarkers and cognition in the aging brain
Fanny Elahi, MD, PhD
10:25 am
Regulation of the blood brain barrier in health and disease
Richard Daneman, PhD
10:45 am
From football players to aging brains - trajectories of vulnerability and resilience to cognitive decline
Daniela Kaufer, PhD
12:20 pm
Single-nucleus transcriptome analysis reveals disease- and regeneration-associated endothelial cells and candidate mechanistic molecular systems in white matter vascular dementia
S. Thomas Carmichael, MD, PhD
12:45 pm
APOE4 Impairs Myelination via Cholesterol Dysregulation in Oligodendrocytes
Joel Blanchard, PhD
1:10 pm
Cerebral microhemorrhages in the aging white matter
Stefano Tarantini, PhD
2:10 pm
Algorithms to Assess Neurovascular Coupling Characteristics at Bedside
Xiao Hu
2:35 pm
Age-related changes of neurovascular coupling and global brain network function and its association to cognitive performance in human subjects
Andriy Yabluchanskiy, MD, PhD
March 29, 2022
9:30 am
Influence of endocrine aging on metabolic and vascular contributions to dementia
10:10 am
Cerebral microvascular alterations induced by menopause: implications for cognitive impairment
Paulo W. Pires, PhD
11:25 am
Geroprotection and the treadmill: exercise and the aging brain
Constanza J. Cortes, PhD
11:50 am
The effects of physical activity on white matter integrity in healthy aging
Chelsea Stillman Coyle, PhD
12:15 pm
The brain-kidney axis
Aditi Gupta, MD, MS
1:40 pm
Understanding degenerative disease mechanisms in the white matter using advanced MRI
Swati Rane Levendovsky, PhD
2:00 pm
Blood pressure control: Updated insights into a randomized clinical trial-proven approach to reducing risk for cognitive impairment and dementia
